304 related articles for article (PubMed ID: 16705554)
1. A diagnostic dilemma in diagnosing and managing an incidental phaeochromocytoma.
Tahrani AA; Macleod AF
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):204-7. PubMed ID: 16705554
[TBL] [Abstract][Full Text] [Related]
2. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
[TBL] [Abstract][Full Text] [Related]
3. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines.
Derlin T; Busch JD; Wisotzki C; Schoennagel BP; Bannas P; Papp L; Klutmann S; Habermann CR
Clin Nucl Med; 2013 Jan; 38(1):e1-6. PubMed ID: 22996238
[TBL] [Abstract][Full Text] [Related]
4. 123I-metaiodobenzylguanidine scans in phaeochromocytoma diagnosis: current clinical practice and relationship to biochemical screening.
Tormey WP; Keeling F; Lee MJ
Int J Clin Pract; 1999 Sep; 53(6):428-32. PubMed ID: 10622069
[TBL] [Abstract][Full Text] [Related]
5. [Nuclear medicine diagnosis of pheochromocytoma with metaiodobenzylguanidine].
Pucar D; Marković S
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():20-4. PubMed ID: 12584993
[TBL] [Abstract][Full Text] [Related]
6. [Hereditary phaeochromocytoma in twins].
Tóth G; Patócs A; Tóth M
Orv Hetil; 2016 Aug; 157(33):1326-30. PubMed ID: 27523316
[TBL] [Abstract][Full Text] [Related]
7. [Pheochromocytoma].
Arnault-Ouary G; Chatal JF; Charbonnel B
Rev Prat; 1998 Apr; 48(7):744-8. PubMed ID: 11767369
[TBL] [Abstract][Full Text] [Related]
8. Meta-iodobenzylguanidine (MIBG) scanning in the diagnosis of phaeochromocytoma.
Clesham CJ; Kennedy A; Lavender JP; Dollery CT; Wilkins MR
J Hum Hypertens; 1993 Aug; 7(4):353-6. PubMed ID: 8410925
[TBL] [Abstract][Full Text] [Related]
9. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
Yokoyama H; Tsuji Y
Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357
[TBL] [Abstract][Full Text] [Related]
10. Incidental adrenal mass hampers the diagnosis of an extra-adrenal phaeochromocytoma.
Jeck T; Keller U
Horm Res; 1996; 46(6):282-3. PubMed ID: 9064278
[TBL] [Abstract][Full Text] [Related]
11. Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations.
Plouin PF; Duclos JM; Menard J; Comoy E; Bohuon C; Alexandre JM
Br Med J (Clin Res Ed); 1981 Mar; 282(6267):853-4. PubMed ID: 6783201
[TBL] [Abstract][Full Text] [Related]
12. A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction.
Defeudis G; Fioriti E; Palermo A; Tuccinardi D; Minucci A; Capoluongo E; Pozzilli P; Manfrini S
Hormones (Athens); 2018 Jun; 17(2):279-284. PubMed ID: 29860716
[TBL] [Abstract][Full Text] [Related]
13. Phaeochromocytoma in a 86-year-old patient presenting with reversible myocardial dysfunction.
Szwench E; P Czkowska M; Marczewski K; Klisiewicz A; Micha Owska I; Ciuba I; Januszewicz M; Prejbisz A; Hoffman P; Januszewicz A
Blood Press; 2011 Dec; 20(6):383-6. PubMed ID: 21675829
[TBL] [Abstract][Full Text] [Related]
14. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.
De Graaf JS; Dullaart RP; Kok T; Piers DA; Zwierstra RP
Eur J Surg; 2000 Apr; 166(4):289-92. PubMed ID: 10817323
[TBL] [Abstract][Full Text] [Related]
15. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
16. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
17. Unusual presentation of phaeochromocytoma.
Hope DC; Palan JM
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27166010
[TBL] [Abstract][Full Text] [Related]
18. Traumatic haemorrhage into an occult phaeochromocytoma: presentation and management in a patient with septic shock.
Saxena N; Parry-Jones AJ
Anaesthesia; 2008 Apr; 63(4):428-32. PubMed ID: 18336495
[TBL] [Abstract][Full Text] [Related]
19. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.
Sawka AM; Jaeschke R; Singh RJ; Young WF
J Clin Endocrinol Metab; 2003 Feb; 88(2):553-8. PubMed ID: 12574179
[TBL] [Abstract][Full Text] [Related]
20. [Malignant pheochromocytoma of the adrenal gland. Diagnosis 14 years after an incidental discovery of a contralateral pheochromocytoma].
Armaroli R; Cremonini N; Lacava N; Talarico F; Spangaro M
Ann Chir; 1994; 48(2):206-9. PubMed ID: 8192416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
